A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-005-9049-zPMID 16244786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.

  2004cited by this paper
• Improved survival in women with BRCA‐associated ovarian carcinoma

  2003influential reference
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair

  2002cited by this paper
• Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.

  2002cited by this paper
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

  2001cited by this paper
• Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.

  2000cited by this paper
• Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

  2000cited by this paper
• Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.

  2000cited by this paper
• Evidence of a founder BRCA1 mutation in Scotland

  2000cited by this paper
• A survey of the current clinical facilities for the management of familial cancer in Europe

  2000cited by this paper
• The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

  1999cited by this paper
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999cited by this paper
• BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

  1998cited by this paper
• Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

  1998cited by this paper
• Survival of patients with breast cancer and BRCA1 mutations

  1998cited by this paper
• Germline BRCA1 185delAG mutations in Jewish women with breast cancer.

  1996cited by this paper
• Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• The genetic epidemiology of BRCA1

  1994cited by this paper
• The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium.

  1994cited by this paper

• Curriculum

  2020cites this paper
• A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer

  2019cites this paper
• The Clinical Significance of Unknown Sequence Variants in BRCA Genes

  2010cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses

  2007cites this paper
• 4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).

  2007cites this paper
• Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

  2006cites this paper